Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …

Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …

The continued evolution of SARS-CoV-2 has led to the emergence of several new Omicron
subvariants, including BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2. Here, we examine the …

BNT162b2-vaccinated individuals after Omicron BA. 1 breakthrough infection have strong
serum-neutralizing activity against Omicron BA. 1, BA. 2, and previous SARS-CoV-2 variants …

The pathogenic and cross-species transmission potential of SARS-CoV-2-related
coronaviruses (CoVs) remain poorly characterized. Here we recovered a wild-type pangolin …

Infection with SARS-CoV-2 variant Omicron is considered to be less severe than infection
with variant Delta, with rarer occurrence of severe disease requiring intensive care. Little …

Continued evolution of SARS-CoV-2 has led to the emergence of several new Omicron
subvariants, including BQ. 1, BQ. 1.1, BA. 4.6, BF. 7 and BA. 2.75. 2. Here we examine the …

Summary In November 2021, Omicron BA. 1, containing a raft of new spike mutations,
emerged and quickly spread globally. Intense selection pressure to escape the antibody …

The SARS-CoV-2 Omicron variant and its sublineages show pronounced viral escape from
neutralizing antibodies elicited by vaccination or prior SARS-CoV-2 variant infection owing …

Portable assays for the rapid identification of lineages of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to aid large-scale efforts in monitoring the …